Differences in Clinical Manifestations and Islet Autoantibodies by Age in Adult-Onset Type 1 Diabetes
Diabetes Care · 01.07.2026 · 49 (7) · 1194-1201
DOI: 10.2337/dc25-2660 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes Care, online erschienen am 02.04.2026. Verfasst von Kagan E Karakus und 10 weiteren Autor:innen. Beteiligte Einrichtung: Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Autoantibodies, Islets of Langerhans. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Division of Diabetes, Endocrinology, and Metabolic Diseases.
Themen: Diabetes mellitus
Abstract (Originalsprache)
OBJECTIVE Adult-onset type 1 diabetes is not well characterized, especially after 40 years of age, and is commonly misdiagnosed as type 2 diabetes. We evaluated the differences in clinical presentation, islet autoantibodies, and HLA genetics between pediatric- and adult-onset type 1 diabetes. RESEARCH DESIGN AND METHODS Individuals who were newly diagnosed with type 1 diabetes were tested for islet autoantibodies within 1 year of diagnosis in this retrospective study. Islet autoantibodies against GAD, insulin, islet antigen 2, and zinc transporter 8 were measured using fluid-phase radiobinding assays. High-resolution HLA class I (n = 655) and II (n = 1,196) typing was performed in a subset of participants. RESULTS In total, 414 adults (aged ≥20 years) and 2,000 children were included. Adults were aged 20–76 years and had a mean BMI of 23.5 ± 4.7 kg/m2 at onset. Compared with children, adults presented with diabetic ketoacidosis (DKA) less frequently (32.6% vs. 56.0%; P < 0.001) and with slightly lower HbA1c values (11.3% ± 2.6% vs. 12.0% ± 2.4%; P < 0.001). Notably, adults older than 40 years (n = 84) presented with DKA only 13.1% of the time. Adults more often presented with zero or one islet autoantibodies compared with children (43.0% vs. 20.2%; P < 0.001). There were no differences in high-risk HLA haplotypes between adults and children (DR4-DQ8: 57.1% vs. 63.7%; P = 0.060; DR3-DQ2: 43.6% vs. 46.1%; P = 0.482). CONCLUSIONS Adult-onset type 1 diabetes is characterized by a reduced frequency of DKA and by fewer total islet autoantibodies. Our findings can help in the accurate diagnosis of type 1 diabetes in adults.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO.
- Lewis Katz School of Medicine, Temple University/St Luke's University Health Network, Bethlehem, PA.
ORCID-Profile: Liping Yu, Sarit Polsky, Halis K Akturk, Satish K Garg, Aaron W Michels
Förderung
- Division of Diabetes, Endocrinology, and Metabolic Diseases
Zitieren
APA
Karakus, K. E., Clayton, M. G., Baschal, E. E., McDaniel, K. A., Yu, L., Haider, Z., Polsky, S., Akturk, H. K., Gottlieb, P. A., Garg, S. K., & Michels, A. W. (2026). Differences in Clinical Manifestations and Islet Autoantibodies by Age in Adult-Onset Type 1 Diabetes. Diabetes Care, 49(7), 1194-1201. https://doi.org/10.2337/dc25-2660
Vancouver
Karakus KE, Clayton MG, Baschal EE, McDaniel KA, Yu L, Haider Z, et al. Differences in Clinical Manifestations and Islet Autoantibodies by Age in Adult-Onset Type 1 Diabetes. Diabetes Care. 2026;49(7):1194-1201. doi:10.2337/dc25-2660
BibTeX
@article{Karakus2026,
author = {Karakus, Kagan E and Clayton, Maia G and Baschal, Erin E and McDaniel, Kristen A and Yu, Liping and Haider, Zehra and Polsky, Sarit and Akturk, Halis K and Gottlieb, Peter A and Garg, Satish K and Michels, Aaron W},
title = {Differences in Clinical Manifestations and Islet Autoantibodies by Age in Adult-Onset Type 1 Diabetes},
journal = {Diabetes Care},
year = {2026},
volume = {49},
number = {7},
pages = {1194--1201},
doi = {10.2337/dc25-2660}
}
EUVIMED